Anti PD-1 Checkpoint Inhibitor As a First-Line Treatment for Advanced Cutaneous Squamous Cell Carcinoma.

Bopota, Katerina; Donnelly, Oliver; Borumandi, Farzad

Bopota, Katerina; Donnelly, Oliver; Borumandi, Farzad.

Affiliation

Bopota K; Department of Oral and Maxillofacial Surgery, University Hospitals Sussex NHS Foundation Trust, St Richard's Hospital, Chichester, Worthing Hospital, Worthing, UK.
Donnelly O; Oncology Unit, Queen Alexandra Hospital, Portsmouth, UK.
Borumandi F; Department of Oral and Maxillofacial Surgery, University Hospitals Sussex NHS Foundation Trust, St Richard's Hospital, Chichester, Worthing Hospital, Worthing, UK.

J Craniofac Surg ; 34(3): e247-e249, 2023 May 01.

Article in En | MEDLINE | ID: mdl-36441840

Subject(s)

Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Skin Neoplasms; Humans; Carcinoma, Squamous Cell/drug therapy; Carcinoma, Squamous Cell/surgery; Immune Checkpoint Inhibitors/therapeutic use; Skin Neoplasms/drug therapy; Skin Neoplasms/surgery; Antineoplastic Agents, Immunological/therapeutic use; Antibodies, Monoclonal/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Antineoplastic Agents, Immunological Limits: Humans Language: En Journal: J Craniofac Surg Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google